No Data
No Data
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
Exagen(XGN.US) Officer Buys US$77,569.92 in Common Stock
Exagen Inc (XGN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Margin ...
Exagen Is Maintained at Overweight by Cantor Fitzgerald
Exagen Price Target Raised to $7.00/Share From $5.00 by Cantor Fitzgerald
Express News | Cantor Fitzgerald Maintains Overweight on Exagen, Raises Price Target to $7
No Data